DK1294689T3 - Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK1294689T3
DK1294689T3 DK01954059T DK01954059T DK1294689T3 DK 1294689 T3 DK1294689 T3 DK 1294689T3 DK 01954059 T DK01954059 T DK 01954059T DK 01954059 T DK01954059 T DK 01954059T DK 1294689 T3 DK1294689 T3 DK 1294689T3
Authority
DK
Denmark
Prior art keywords
perindopril
preparation
pharmaceutical compositions
crystalline form
compositions containing
Prior art date
Application number
DK01954059T
Other languages
Danish (da)
English (en)
Inventor
Stephane Beilles
Yves-Michel Ginot
Gerard Coquerel
Bruno Pfeiffer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1294689T3 publication Critical patent/DK1294689T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01954059T 2000-07-06 2001-07-06 Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK1294689T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0008792A FR2811319B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
DK1294689T3 true DK1294689T3 (da) 2006-08-28

Family

ID=8852171

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01954059T DK1294689T3 (da) 2000-07-06 2001-07-06 Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (36)

Country Link
US (2) US20040029813A1 (hr)
EP (2) EP1676839A3 (hr)
JP (2) JP3592297B2 (hr)
KR (1) KR100513571B1 (hr)
CN (1) CN1328260C (hr)
AP (1) AP1407A (hr)
AR (1) AR029571A1 (hr)
AT (1) ATE324367T1 (hr)
AU (2) AU7641901A (hr)
BG (1) BG66131B1 (hr)
BR (1) BR0112244A (hr)
CA (1) CA2415442C (hr)
CZ (1) CZ301765B6 (hr)
DE (1) DE60119107T2 (hr)
DK (1) DK1294689T3 (hr)
EA (1) EA004874B1 (hr)
EE (1) EE05285B1 (hr)
ES (1) ES2262666T3 (hr)
FR (1) FR2811319B1 (hr)
GE (1) GEP20043360B (hr)
HK (1) HK1058200A1 (hr)
HR (2) HRP20030079B8 (hr)
HU (1) HU227673B1 (hr)
ME (1) ME00440B (hr)
MX (1) MXPA02012921A (hr)
NO (1) NO323446B1 (hr)
NZ (1) NZ523234A (hr)
OA (1) OA12305A (hr)
PL (1) PL348493A1 (hr)
PT (1) PT1294689E (hr)
RS (1) RS51717B (hr)
SI (1) SI1294689T1 (hr)
SK (1) SK286918B6 (hr)
UA (1) UA57189C2 (hr)
WO (1) WO2001087836A1 (hr)
ZA (1) ZA200300024B (hr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
KR20060035636A (ko) * 2003-06-24 2006-04-26 르 라보레또레 쎄르비에르 신규한 결정형의 페린도프릴 에르부민
ES2336554T3 (es) 2003-10-21 2010-04-14 Les Laboratoires Servier Nuevo metodo para la preparacion de perindopril erbumina cristalina.
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
PT1729739T (pt) 2004-03-29 2016-12-01 Servier Lab Processo para a preparação de uma composição farmacêutica sólida
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
MX2008002066A (es) * 2005-08-12 2008-04-16 Sandoz Ag Neuva forma cristalina de perindopril-erbumina.
EP1943267B1 (en) * 2005-08-12 2011-03-16 LEK Pharmaceuticals d.d. A process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2008050185A2 (en) * 2006-10-26 2008-05-02 Glenmark Pharmaceuticals Limited Novel polymorphs of perindopril erbumine
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
EP2682388B1 (en) * 2008-06-24 2018-01-10 Mylan Laboratories Limited Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN106432042A (zh) * 2015-08-13 2017-02-22 南京华威医药科技开发有限公司 尼达尼布乙磺酸水合物的药物新晶型
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
YU100502A (sh) 2003-08-29
EP1294689A1 (fr) 2003-03-26
US20040029813A1 (en) 2004-02-12
EE05285B1 (et) 2010-04-15
HK1058200A1 (en) 2004-05-07
CZ301765B6 (cs) 2010-06-16
US7259181B2 (en) 2007-08-21
EA004874B1 (ru) 2004-08-26
NZ523234A (en) 2005-01-28
BG107533A (bg) 2003-11-28
FR2811319B1 (fr) 2002-08-23
BG66131B1 (bg) 2011-06-30
ATE324367T1 (de) 2006-05-15
AP2002002710A0 (en) 2002-12-31
KR20030016368A (ko) 2003-02-26
GEP20043360B (en) 2004-06-10
AU7641901A (en) 2001-11-26
HRP20060361A2 (hr) 2008-06-30
HRP20030079A2 (en) 2003-04-30
SI1294689T1 (sl) 2006-08-31
CA2415442A1 (fr) 2001-11-22
HUP0102813A2 (hu) 2002-03-28
ZA200300024B (en) 2004-02-05
EP1676839A3 (fr) 2006-11-08
CZ2003356A3 (cs) 2003-05-14
PT1294689E (pt) 2006-07-31
PL348493A1 (en) 2002-01-14
KR100513571B1 (ko) 2005-09-09
DE60119107D1 (de) 2006-06-01
BR0112244A (pt) 2003-06-24
NO20030050D0 (no) 2003-01-06
DE60119107T2 (de) 2006-12-07
HU227673B1 (hu) 2011-11-28
OA12305A (en) 2003-12-29
HRP20030079B8 (hr) 2008-09-30
JP2003533508A (ja) 2003-11-11
AU2001276419B2 (en) 2006-11-16
FR2811319A1 (fr) 2002-01-11
UA57189C2 (uk) 2003-06-16
NO323446B1 (no) 2007-05-07
HRP20060361A8 (hr) 2008-07-31
EP1676839A2 (fr) 2006-07-05
RS51717B (sr) 2011-10-31
SK1482003A3 (en) 2003-06-03
ES2262666T3 (es) 2006-12-01
EA200300103A1 (ru) 2003-06-26
HRP20030079B1 (hr) 2007-12-31
SK286918B6 (sk) 2009-07-06
CN1328260C (zh) 2007-07-25
MXPA02012921A (es) 2004-07-30
WO2001087836A1 (fr) 2001-11-22
HUP0102813A3 (en) 2003-12-29
HU0102813D0 (en) 2001-09-28
JP3592297B2 (ja) 2004-11-24
JP2005002121A (ja) 2005-01-06
AP1407A (en) 2005-05-30
EE200300002A (et) 2004-08-16
US20050203165A1 (en) 2005-09-15
NO20030050L (no) 2003-01-06
ME00440B (me) 2011-10-10
AR029571A1 (es) 2003-07-02
EP1294689B1 (fr) 2006-04-26
CA2415442C (fr) 2009-01-27
CN1440388A (zh) 2003-09-03

Similar Documents

Publication Publication Date Title
DK1294689T3 (da) Ny beta-krystallinsk form af t-butylaminsaltet af perindopril, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1296948T3 (da) N-gamma-krystallinsk form af perindopril-t-butylaminsalt, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dette
DK2128246T3 (da) Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1163227T3 (da) Bicykliske heterocykliske forbindelser, farmaceutiske præparater indeholdende disse forbindelser og fremgangsmåder til fremstilling deraf
DK1066049T3 (da) Farmaceutiske præparater, der er beregnet til langvarig frigivelse af peptider og fremgangsmåde til fremstilling af disse
DK1326585T4 (da) Fremgangsmåde til fremstilling af pulverformuleringer
DK1320531T3 (da) Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
IS7226A (is) Fjölbrigða form af rimonabant, framleiðsluaðferð og lyfjasamsetningar sem innihalda það
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
HUP0402554A3 (en) Condensated heterocyclic succinimide compounds, their use, process for the preparation of some of them and pharmaceutical compositions containing the compounds
IS6906A (is) Afleiður af N-(arýlsúlfónýl)beta-amínósýrum sem samanstanda af setnum amínómetýl hópi, aðferð til framleiðslu á afleiðum og lyfjafræðilegar samsetningar sem innihalda þær
IS6531A (is) Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
IS6677A (is) Amínóalkýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningarsem innihalda þær
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
DK1558612T3 (da) Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
DK1171444T3 (da) Pyridothienodiazepiner, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
DK1245565T3 (da) Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater